Browse Studies — Arctuva

Observational

QAIAx (AIhealth4U) - AI Smart Health Cities: Microcity Enclave Program (UPSTO App No(s). 64/074,526, 64/063,557, 64/105,164, 63/903,181, 63/729,428) is Frontier AI/AGI Public Health Trials Sandbox Framework That Provides Free Public Health Services to Registered and Sponsored Visitors/Occupants for RDT&E Under 28 U.S.C. 1498 (Classified as a PPA, OTA Under 10 U.S. Code 4001, 4022), Serving as a Global Intranet of Humans Resident Patients Among Multiple Enclave Communicates ("AI Microcities" or "Smart Health Cities") Living and Learning With AI Robotics for Non-medicinal Treatment.

BRIEF SUMMARY A. "What is the purpose of this study?" BACKGROUND. The QAIAx clinical trial (Quantum AI/AGI Public Health Agency), known operationally as the …

Asperger's DisorderAsperger DisorderAutism Disorder+41 more

Estimated

~$10 – $5,625

Veterans Recovery Network Inc.NCT07661823

Phase 1

Psilocybin Administration With 5-HT1a Blockade

The purpose of this study is to assess the effects of 5-HT1A receptor blockade on the acute subjective effects of psilocybin, as measured through subjective su…

Psychedelic Effects in Healthy Volunteers

Estimated

~$10 – $6,250

Johns Hopkins UniversityNCT07565493

Phase 1

Investigation of Psychedelic Effects in Psychoactive Substances

The aim of this double-blind, placebo-controlled, within-subjects study is to determine whether other psychoactive substances can produce experiences akin to t…

Psychedelic Effects in Healthy Volunteers

Estimated

~$10 – $6,250

Johns Hopkins UniversityNCT06772753